VALNEVA (EPA:VLA) | WebDisclosure

Basculer en Français

10812	Companies
234244	Keywords
163039	Articles
125257	Press releases

Home
Companies
VALNEVA

BRIEF

published on 04/18/2025 at 10:05, 1 year 3 months ago

Valneva Updates on Chikungunya Vaccine Recommendation in the U.S.

Valneva Chikungunya Vaccine IXCHIQ® ACIP Recommendation U.S. Travelers
BRIEF

published on 04/18/2025 at 10:05, 1 year 3 months ago

Valneva met à jour sa recommandation concernant le vaccin contre le chikungunya aux États-Unis

Valneva Voyageurs Américains Vaccin Contre Le Chikungunya IXCHIQ® Recommandation De L'ACIP
PRESS RELEASE

published on 04/18/2025 at 10:00, 1 year 3 months ago

Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers
Valneva provides update on ACIP recommendation for its chikungunya vaccine IXCHIQ® among U.S. travelers, highlighting new precaution for persons aged 65 years and ongoing safety monitoring

Valneva CDC Chikungunya Vaccine IXCHIQ® ACIP Recommendation
PRESS RELEASE

published on 04/18/2025 at 10:00, 1 year 3 months ago

Valneva fait le point sur la recommandation de l'ACIP pour les voyageurs américains concernant son vaccin IXCHIQ® contre le chikungunya
Valneva fait le point sur la recommandation de l'ACIP pour les voyageurs américains concernant son vaccin IXCHIQ® contre le chikungunya

Valneva Vaccin Chikungunya IXCHIQ® ACIP
BRIEF

published on 04/09/2025 at 07:05, 1 year 3 months ago

Vaccination du premier enfant dans l'étude de Phase 2 sur le vaccin S4V2 contre la shigellose

Valneva Phase 2 Shigellose Vaccin S4V2 Essai Pédiatrique
BRIEF

published on 04/09/2025 at 07:05, 1 year 3 months ago

First child vaccinated in Phase 2 study of S4V2 shigellosis vaccine

Valneva Phase 2 Shigellosis S4V2 Vaccine Pediatric Trial
PRESS RELEASE

published on 04/09/2025 at 07:00, 1 year 3 months ago

Valneva et LimmaTech annoncent la vaccination du premier participant à l’étude pédiatrique de Phase 2 du candidat vaccin tétravalent contre la shigellose S4V2
Valneva et LimmaTech annoncent la vaccination du premier participant à l’étude pédiatrique de Phase 2 du candidat vaccin tétravalent contre la shigellose S4V2

Valneva Vaccin Shigellose LimmaTech Étude Pédiatrique
PRESS RELEASE

published on 04/09/2025 at 07:00, 1 year 3 months ago

Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2
Valneva and LimmaTech announce first vaccination in Phase 2 infant study of tetravalent Shigella vaccine candidate S4V2. Study aims to combat shigellosis, a deadly diarrheal disease

Valneva Phase 2 Study Shigella Vaccine Shigellosis LimmaTech
PRESS RELEASE

published on 03/20/2025 at 07:00, 1 year 4 months ago

Valneva publie ses résultats financiers 2024 et fait un point sur son activité et ses perspectives financières
PRESS RELEASE

published on 03/20/2025 at 07:00, 1 year 4 months ago

Valneva Reports Full Year 2024 Results and Provides Business Updates and Outlook
Valneva SE reports solid full year 2024 results exceeding growth targets. Financial outlook for 2025 includes strong revenue growth and strategic investments. Key milestones and financial information discussed

Financial Results Valneva 2025 Outlook Vaccine Company Clinical Progress

Accesswire

Published on 08/08/2026 at 00:00, 19 hours 48 minutes ago

Boron One Announces Change of Auditor
Published on 08/07/2026 at 23:15, 20 hours 33 minutes ago

Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 20 hours 48 minutes ago

Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 21 hours 18 minutes ago

UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 21 hours 33 minutes ago

Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services

View all ACCESSWIRE

EQS Group

Published on 08/08/2026 at 16:25, 3 hours 22 minutes ago

Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 20 hours 27 minutes ago

EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 1 day ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 1 day ago

ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 1 day 1 hour ago

Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request

Les Echos

Published on 08/07/2026 at 18:54, 1 day ago

Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 1 day ago

Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 1 day 1 hour ago

Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 1 day 1 hour ago

Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 1 day 1 hour ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026

View all LES ECHOS COMFI WIRE